Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-11-01 Other |
2024-11-05 6:35 pm |
N/A N/A |
Lomond Therapeutics Holdings Inc. | Tompkins Mark N. Former Director Director |
3,550,000 | $0 | 4,750,000 (Direct) |
View | |
| 2024-11-01 Other |
2024-11-05 6:33 pm |
N/A N/A |
Lomond Therapeutics Holdings Inc. | Jacobs Ian Seth Former Director and officer Director |
75,000 | $0 | 250,000 (Direct) |
View | |
| 2024-11-01 Conversion |
2024-11-05 6:02 pm |
N/A N/A |
Lomond Therapeutics Holdings Inc. | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Capital GP VIII LLC OrbiMed Capital GP IX LLC Director |
694,444 | $3.6 | 2,677,256 (Indirect) |
View | |
| 2024-11-01 Conversion |
2024-11-05 6:02 pm |
N/A N/A |
Lomond Therapeutics Holdings Inc. | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Capital GP VIII LLC OrbiMed Capital GP IX LLC Director |
1,233,506 | $0 | 2,677,256 (Indirect) |
View | |
| 2024-11-01 Conversion |
2024-11-05 6:02 pm |
N/A N/A |
Lomond Therapeutics Holdings Inc. | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Capital GP VIII LLC OrbiMed Capital GP IX LLC Director |
539,062 | $3.2 | 2,677,256 (Indirect) |
View | |
| 2024-11-01 Option Award |
2024-11-05 6:02 pm |
N/A N/A |
Lomond Therapeutics Holdings Inc. | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Capital GP VIII LLC OrbiMed Capital GP IX LLC Director |
1,443,750 | $4 | 2,677,256 (Indirect) |
View | |
| 2024-11-01 Conversion |
2024-11-05 6:01 pm |
N/A N/A |
Lomond Therapeutics Holdings Inc. | GORDON CARL L Director |
694,444 | $3.6 | 2,677,256 (Indirect) |
View | |
| 2024-11-01 Conversion |
2024-11-05 6:01 pm |
N/A N/A |
Lomond Therapeutics Holdings Inc. | GORDON CARL L Director |
1,233,506 | $0 | 2,677,256 (Indirect) |
View | |
| 2024-11-01 Conversion |
2024-11-05 6:01 pm |
N/A N/A |
Lomond Therapeutics Holdings Inc. | GORDON CARL L Director |
539,062 | $3.2 | 2,677,256 (Indirect) |
View | |
| 2024-11-01 Option Award |
2024-11-05 6:01 pm |
N/A N/A |
Lomond Therapeutics Holdings Inc. | GORDON CARL L Director |
1,443,750 | $4 | 2,677,256 (Indirect) |
View | |
| 2024-11-01 Option Award |
2024-11-05 6:00 pm |
N/A 2034-09-18 |
Lomond Therapeutics Holdings Inc. | Savchuk Nikolay President and COO |
1,258,000 | $0 | 3,935,256 (Direct) |
View | |
| 2024-11-01 Conversion |
2024-11-05 6:00 pm |
N/A N/A |
Lomond Therapeutics Holdings Inc. | Savchuk Nikolay President and COO |
694,444 | $3.6 | 3,935,256 (Indirect) |
View | |
| 2024-11-01 Conversion |
2024-11-05 6:00 pm |
N/A N/A |
Lomond Therapeutics Holdings Inc. | Savchuk Nikolay President and COO |
1,233,506 | $0 | 3,935,256 (Indirect) |
View | |
| 2024-11-01 Conversion |
2024-11-05 6:00 pm |
N/A N/A |
Lomond Therapeutics Holdings Inc. | Savchuk Nikolay President and COO |
539,062 | $3.2 | 3,935,256 (Indirect) |
View | |
| 2024-11-01 Option Award |
2024-11-05 6:00 pm |
N/A N/A |
Lomond Therapeutics Holdings Inc. | Savchuk Nikolay President and COO |
1,443,750 | $4 | 3,935,256 (Indirect) |
View | |
| 2024-11-01 Option Award |
2024-11-05 6:00 pm |
N/A 2034-09-18 |
Lomond Therapeutics Holdings Inc. | Dukes Iain D. CEO and Chairman |
2,096,667 | $0 | 2,096,667 (Direct) |
View | |
Ownership |
2024-11-05 5:57 pm |
N/A N/A |
Lomond Therapeutics Holdings Inc. | Eilean Therapeutics LLC 10% Owner |
0 | $0 | 14,420,383 (Direct) |
View | |
Ownership |
2022-02-10 9:30 pm |
N/A N/A |
Venetian-1 Acquisition Corp. | Tompkins Mark N. Director 10% Owner |
0 | $0 | 4,750,000 (Direct) |
View | |
Ownership |
2022-02-10 9:30 pm |
N/A N/A |
Venetian-1 Acquisition Corp. | Jacobs Ian Seth President, CEO, CFO, Secretary 10% Owner |
0 | $0 | 250,000 (Direct) |
View |